• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Docking to large allosteric binding sites on protein surfaces.对接蛋白质表面的大变构结合位点。
Adv Exp Med Biol. 2010;680:481-8. doi: 10.1007/978-1-4419-5913-3_54.
2
Porphobilinogen synthase: An equilibrium of different assemblies in human health.卟啉原氧化酶:人类健康中不同聚集体的平衡。
Prog Mol Biol Transl Sci. 2020;169:85-104. doi: 10.1016/bs.pmbts.2019.11.003. Epub 2019 Dec 6.
3
Allostery and the dynamic oligomerization of porphobilinogen synthase.变构作用与卟胆原合酶的动态寡聚化。
Arch Biochem Biophys. 2012 Mar 15;519(2):144-53. doi: 10.1016/j.abb.2011.10.010. Epub 2011 Oct 19.
4
Allosteric inhibition of human porphobilinogen synthase.别构抑制人卟胆原合酶。
J Biol Chem. 2009 Dec 18;284(51):35807-17. doi: 10.1074/jbc.M109.026294.
5
The Remarkable Character of Porphobilinogen Synthase.原卟啉原 IX 合酶的显著特征。
Acc Chem Res. 2016 Nov 15;49(11):2509-2517. doi: 10.1021/acs.accounts.6b00414. Epub 2016 Oct 26.
6
Single amino acid mutations alter the distribution of human porphobilinogen synthase quaternary structure isoforms (morpheeins).单个氨基酸突变会改变人胆色素原合酶四级结构异构体(形态素)的分布。
J Biol Chem. 2006 Mar 10;281(10):6682-90. doi: 10.1074/jbc.M511134200. Epub 2005 Dec 23.
7
Probing the oligomeric assemblies of pea porphobilinogen synthase by analytical ultracentrifugation.通过分析超速离心法探究豌豆胆色素原合酶的寡聚体组装体
Biochemistry. 2008 Oct 7;47(40):10649-56. doi: 10.1021/bi801128d. Epub 2008 Sep 17.
8
Shape shifting leads to small-molecule allosteric drug discovery.构象转变推动小分子变构药物的发现。
Chem Biol. 2008 Jun;15(6):586-96. doi: 10.1016/j.chembiol.2008.04.012.
9
Biochemical and molecular characterization of a novel porphobilinogen synthase from Corynebacterium glutamicum.从谷氨酸棒杆菌中新型的卟胆原合酶的生化和分子特征。
World J Microbiol Biotechnol. 2023 Apr 18;39(6):165. doi: 10.1007/s11274-023-03615-2.
10
Control of tetrapyrrole biosynthesis by alternate quaternary forms of porphobilinogen synthase.通过胆色素原合酶的交替四级结构形式控制四吡咯生物合成。
Nat Struct Biol. 2003 Sep;10(9):757-63. doi: 10.1038/nsb963. Epub 2003 Aug 3.

引用本文的文献

1
Re-Exploring the Ability of Common Docking Programs to Correctly Reproduce the Binding Modes of Non-Covalent Inhibitors of SARS-CoV-2 Protease M.重新探索常见对接程序正确再现严重急性呼吸综合征冠状病毒2蛋白酶M非共价抑制剂结合模式的能力。
Pharmaceuticals (Basel). 2022 Jan 31;15(2):180. doi: 10.3390/ph15020180.
2
Repurposing of FDA-approved drugs against active site and potential allosteric drug-binding sites of COVID-19 main protease.重新利用美国食品和药物管理局批准的药物来对抗 COVID-19 主蛋白酶的活性位点和潜在的变构药物结合位点。
Proteins. 2021 Nov;89(11):1425-1441. doi: 10.1002/prot.26164. Epub 2021 Jul 5.
3
Targeting the C-Terminal Domain Small Phosphatase 1.靶向C端结构域小磷酸酶1
Life (Basel). 2020 May 8;10(5):57. doi: 10.3390/life10050057.
4
Porphobilinogen synthase: An equilibrium of different assemblies in human health.卟啉原氧化酶:人类健康中不同聚集体的平衡。
Prog Mol Biol Transl Sci. 2020;169:85-104. doi: 10.1016/bs.pmbts.2019.11.003. Epub 2019 Dec 6.
5
Systematic discovery of molecular probes targeting multiple non-orthosteric and spatially distinct sites in the botulinum neurotoxin subtype A (BoNT/A).针对肉毒杆菌神经毒素A亚型(BoNT/A)中多个非正构且空间上不同位点的分子探针的系统性发现。
Mol Cell Probes. 2015 Jun;29(3):135-43. doi: 10.1016/j.mcp.2015.02.002. Epub 2015 Mar 4.
6
Environmental contaminants perturb fragile protein assemblies and inhibit normal protein function.环境污染物会扰乱脆弱的蛋白质组装体,并抑制正常的蛋白质功能。
Curr Chem Biol. 2013;7(2):196-206. doi: 10.2174/2212796811307020011.
7
Impact of quaternary structure dynamics on allosteric drug discovery.四级结构动力学对变构药物发现的影响。
Curr Top Med Chem. 2013;13(1):55-63. doi: 10.2174/1568026611313010006.
8
A new model for allosteric regulation of phenylalanine hydroxylase: implications for disease and therapeutics.苯丙氨酸羟化酶变构调节的新模型:对疾病和治疗的影响。
Arch Biochem Biophys. 2013 Feb 15;530(2):73-82. doi: 10.1016/j.abb.2012.12.017. Epub 2013 Jan 11.
9
The morpheein model of allostery: evaluating proteins as potential morpheeins.变构的morpheein模型:评估作为潜在morpheein的蛋白质。
Methods Mol Biol. 2012;796:217-31. doi: 10.1007/978-1-61779-334-9_12.
10
Allostery and the dynamic oligomerization of porphobilinogen synthase.变构作用与卟胆原合酶的动态寡聚化。
Arch Biochem Biophys. 2012 Mar 15;519(2):144-53. doi: 10.1016/j.abb.2011.10.010. Epub 2011 Oct 19.

本文引用的文献

1
Allosteric inhibition of human porphobilinogen synthase.别构抑制人卟胆原合酶。
J Biol Chem. 2009 Dec 18;284(51):35807-17. doi: 10.1074/jbc.M109.026294.
2
Probing the oligomeric assemblies of pea porphobilinogen synthase by analytical ultracentrifugation.通过分析超速离心法探究豌豆胆色素原合酶的寡聚体组装体
Biochemistry. 2008 Oct 7;47(40):10649-56. doi: 10.1021/bi801128d. Epub 2008 Sep 17.
3
Shape shifting leads to small-molecule allosteric drug discovery.构象转变推动小分子变构药物的发现。
Chem Biol. 2008 Jun;15(6):586-96. doi: 10.1016/j.chembiol.2008.04.012.
4
Kinetics and thermodynamics of the interchange of the morpheein forms of human porphobilinogen synthase.人胆色素原合酶的形态互换的动力学和热力学
Biochemistry. 2008 Mar 11;47(10):3245-57. doi: 10.1021/bi702113z. Epub 2008 Feb 14.
5
ALAD porphyria is a conformational disease.δ-氨基-γ-酮戊酸脱水酶缺乏性卟啉症是一种构象疾病。
Am J Hum Genet. 2007 Feb;80(2):329-37. doi: 10.1086/511444. Epub 2006 Dec 21.
6
Targeting protein-protein interactions with small molecules: challenges and perspectives for computational binding epitope detection and ligand finding.利用小分子靶向蛋白质-蛋白质相互作用:计算结合表位检测和配体发现的挑战与前景
Curr Med Chem. 2006;13(22):2607-25. doi: 10.2174/092986706778201530.
7
Single amino acid mutations alter the distribution of human porphobilinogen synthase quaternary structure isoforms (morpheeins).单个氨基酸突变会改变人胆色素原合酶四级结构异构体(形态素)的分布。
J Biol Chem. 2006 Mar 10;281(10):6682-90. doi: 10.1074/jbc.M511134200. Epub 2005 Dec 23.
8
Morpheeins--a new structural paradigm for allosteric regulation.变构蛋白——变构调节的一种新结构范式
Trends Biochem Sci. 2005 Sep;30(9):490-7. doi: 10.1016/j.tibs.2005.07.003.
9
Substrate-induced interconversion of protein quaternary structure isoforms.底物诱导的蛋白质四级结构异构体的相互转化。
J Biol Chem. 2005 Apr 22;280(16):15786-93. doi: 10.1074/jbc.M500218200. Epub 2005 Feb 14.
10
Magnitude of the hydrophobic effect at central versus peripheral sites in protein-protein interfaces.蛋白质-蛋白质界面中心与周边位点疏水性效应的强度
Structure. 2005 Feb;13(2):297-307. doi: 10.1016/j.str.2004.12.012.

对接蛋白质表面的大变构结合位点。

Docking to large allosteric binding sites on protein surfaces.

机构信息

Fox Chase Cancer Center, Philadelphia, PA 19111, USA.

出版信息

Adv Exp Med Biol. 2010;680:481-8. doi: 10.1007/978-1-4419-5913-3_54.

DOI:10.1007/978-1-4419-5913-3_54
PMID:20865533
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2946403/
Abstract

The inactive porphobilinogen synthase (PBGS) hexamer has an oligomer-specific and phylogenetically variable surface cavity that is not present in the active octamer. The octamer and hexamer are components of a dynamic quaternary structure equilibrium characteristic of morpheeins. Small molecules that bind to the hexamer-specific surface cavity, which is at the interface of three subunits, are predicted to act as allosteric inhibitors that function by drawing the oligomeric equilibrium toward the hexamer. We used GLIDE as a tool to enrich a 250,000 molecule library for molecules with enhanced probability of acting as hexamer-stabilizing allosteric inhibitors of PBGS from Yersinia enterocolitica. Eighty-six compounds were tested in vitro and five showed hexamer stabilization. We discuss the application of computational docking to surface cavities as an approach to find allosteric modulators of protein function with specific reference to morpheeins that function as an equilibrium of non-additive quaternary structure assemblies.

摘要

无活性的卟胆原合酶(PBGS)六聚体具有一个寡聚体特异性和系统发育上可变的表面腔,该表面腔不存在于活性八聚体中。八聚体和六聚体是 morpheeins 特征的动态四级结构平衡的组成部分。预测与位于三个亚基界面的六聚体特异性表面腔结合的小分子将作为别构抑制剂发挥作用,通过将寡聚平衡拉向六聚体来发挥作用。我们使用 GLIDE 作为工具,从肠炎沙门氏菌中对具有增强作为 PBGS 六聚体稳定的别构抑制剂的可能性的 250,000 种分子文库进行了富集。在体外测试了 86 种化合物,其中 5 种显示出六聚体稳定性。我们讨论了将计算对接应用于表面腔作为寻找蛋白质功能别构调节剂的方法,特别参考了作为非加和四级结构组装平衡的 morpheeins。